KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Non-Current Liabilities (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of Other Non-Current Liabilities data on record, last reported at $42.6 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $42.6 million; the TTM value through Sep 2025 reached $42.6 million, changed N/A, while the annual FY2024 figure was $39.1 million, 35.29% up from the prior year.
  • Other Non-Current Liabilities reached $42.6 million in Q3 2025 per EBS's latest filing, up from $35.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $69.5 million in Q4 2021 and bottomed at $28.9 million in Q4 2023.
  • Average Other Non-Current Liabilities over 5 years is $47.7 million, with a median of $42.0 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 40.29% in 2022, then skyrocketed 35.29% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $69.5 million in 2021, then tumbled by 40.29% to $41.5 million in 2022, then tumbled by 30.36% to $28.9 million in 2023, then skyrocketed by 35.29% to $39.1 million in 2024, then grew by 8.95% to $42.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $42.6 million in Q3 2025, $35.4 million in Q1 2025, and $39.1 million in Q4 2024.